CompletedPhase 2NCT00775593
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
Studying Acute basophilic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Principal Investigator
- Sergio Amadori, MDOspedale Sant' Eugenio
- Intervention
- clofarabine(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 60 years · All sexes
- Timeline
- 2008 – 2013
Study locations (19)
- Azienda ospedaliera Nuovo ospedale "Torrette", Ancona, Italy
- Azienda Ospedaliero-Universitaria Policlinico Consorziale, Bari, Italy
- Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi, Bologna, Italy
- Ospedale Ferrarotto, Catania, Italy
- Ospedale Regionale A. Pugliese, Catanzaro, Italy
- Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli", Naples, Italy
- Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia, Naples, Italy
- S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy
- A.O. Universitaria S. Luigi Gonzaga di Orbassano, Orbassano, Italy
- Azienda Ospedaliero - Universitaria di Parma, Parma, Italy
- Azienda ASL di Pescara, Pescara, Italy
- Complesso Ospedaliero S. Giovanni Addolorata, Roma, Italy
- Ospedale S. Eugenio, Roma, Italy
- S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, Roma, Italy
- Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, Roma, Italy
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00775593 on ClinicalTrials.govOther trials for Acute basophilic leukemia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT01627041Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNCT00898456Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaAlliance for Clinical Trials in Oncology